Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
RAYMOND JAMES FINANCIAL INC
SIC 6211 · Security Brokers, Dealers & Flotation Companies
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
RAYMOND JAMES FINANCIAL INC
SIC 6211 · Security Brokers, Dealers & Flotation Companies
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
RAYMOND JAMES FINANCIAL INC
SIC 6211 · Security Brokers, Dealers & Flotation Companies
Notes
Support
about
terms
$
RJF
RAYMOND JAMES FINANCIAL INC
CIK:
0000720005
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended
9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenues:
Principal transactions
$ 126
$ 128
$ 388
$ 396
Interest income
994
990
2,961
2,980
Total revenues
4,362
3,842
12,800
11,722
Interest expense
(434)
(444)
(1,278)
(1,384)
Net revenues
3,928
3,398
11,522
10,338
Non-interest expenses:
Compensation, commissions and benefits
2,579
2,202
7,570
6,678
Non-compensation expenses:
Communications and information processing
203
191
603
553
Occupancy and equipment
85
77
245
224
Business development
95
77
251
209
Investment sub-advisory fees
63
56
189
163
Professional fees
63
42
136
110
Bank loan provision/(benefit) for credit losses
(26)
15
(24)
31
Other
116
175
339
387
Total non-compensation expenses
599
633
1,739
1,677
Total non-interest expenses
3,178
2,835
9,309
8,355
Total pre-tax income
750
563
2,213
1,983
Provision for income taxes
155
127
511
452
Net income
595
436
1,702
1,531
Preferred stock dividends
0
1
3
4
Net income available to common shareholders, basic
595
435
1,699
1,527
Net income available to common shareholders, diluted
$ 595
$ 435
$ 1,699
$ 1,527
Earnings per common share – basic (in usd per share)
$ 3.06
$ 2.16
$ 8.67
$ 7.51
Earnings per common share – diluted (in usd per share)
$ 3.01
$ 2.12
$ 8.52
$ 7.35
Weighted-average common shares outstanding – basic (in shares)
194.0
201.2
195.7
203.0
Weighted-average common and common equivalent shares outstanding – diluted (in shares)
197.2
205.5
199.1
207.6
Net income
$ 595
$ 436
$ 1,702
$ 1,531
Other comprehensive income/(loss), net of tax:
Available-for-sale securities
(10)
53
23
42
Currency translations, net of the impact of net investment hedges
(2)
58
(5)
24
Cash flow hedges
(1)
(3)
(3)
(2)
Total other comprehensive income/(loss), net of tax
(13)
108
15
64
Total comprehensive income
582
544
1,717
1,595
Asset management and related administrative fees
Revenues:
Revenue from contract with customer
2,075
1,733
6,090
5,201
Total brokerage revenues
Revenues:
Total brokerage revenues
629
559
1,884
1,698
Securities commissions
Revenues:
Revenue from contract with customer
503
431
1,496
1,302
Account and service fees
Revenues:
Revenue from contract with customer
316
302
935
965
Investment banking
Revenues:
Revenue from contract with customer
291
212
778
753
Other
Revenues:
Revenue from contract with customer
$ 57
$ 46
$ 152
$ 125
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Millions
9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:
Net income
$ 1,702
$ 1,531
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
154
143
Deferred income taxes, net
129
(4)
Premium and discount amortization on available-for-sale securities and bank loans and net unrealized gains/losses on other investments
(8)
(19)
Provisions for credit losses and legal and regulatory matters, net
(3)
107
Share-based compensation expense
183
199
Unrealized gains on corporate-owned life insurance policies, net of expenses
(152)
(68)
Other
34
23
Net change in:
Collateralized agreements, net of collateralized financings
(750)
(247)
Loans provided to financial advisors, net of repayments
(471)
(194)
Brokerage client receivables and other receivables, net
(1,139)
(170)
Trading instruments, net
(21)
77
Derivative instruments, net
93
31
Other assets
68
78
Brokerage client payables and other payables
909
331
Accrued compensation, commissions and benefits
(86)
(109)
Proceeds from sales of securitizations and loans held for sale, net of purchases and originations of loans held for sale
201
(71)
Net cash provided by operating activities
843
1,638
Cash flows from investing activities:
Increase in bank loans, net
(5,509)
(4,044)
Proceeds from sales of loans held for investment
615
218
Purchases of available-for-sale securities
(947)
(480)
Available-for-sale securities maturations, repayments and redemptions
1,324
1,531
Proceeds from sales of available-for-sale securities
40
78
Cash paid for acquisitions, net of cash acquired
(484)
0
Additions to property and equipment
(153)
(144)
Sales of Federal Reserve Bank (“FRB”) and Federal Home Loan Bank (“FHLB”) stock
0
8
Equity method investments, net of distributions received
(86)
(24)
Other investing activities, net
(94)
(41)
Net cash used in investing activities
(5,294)
(2,898)
Cash flows from financing activities:
Increase in bank deposits
4,422
1,239
Repurchases of common stock and share-based awards withheld for payment of withholding tax requirements
(1,319)
(914)
Dividends on common and preferred stock
(326)
(314)
Employee stock purchases and exercise of stock options
33
26
Redemption of preferred stock
(81)
0
Proceeds from FHLB advances
400
750
Repayments of FHLB advances
(400)
(950)
Proceeds from short-term borrowings
250
0
Other financing, net
(11)
(8)
Net cash provided by/(used in) financing activities
2,968
(171)
Currency adjustment:
Effect of exchange rate changes on cash and cash equivalents, including those segregated for regulatory purposes
(50)
48
Net decrease in cash and cash equivalents, including those segregated for regulatory purposes and restricted cash
(1,533)
(1,383)
Cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at beginning of year
14,787
14,348
Cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at end of period
13,254
12,965
Cash and cash equivalents, including those segregated for regulatory purposes and restricted cash
Cash and cash equivalents
9,977
9,195
Cash and cash equivalents segregated for regulatory purposes and restricted cash
3,277
3,770
Total cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at end of period
13,254
12,965
Supplemental disclosures of cash flow information:
Cash paid for interest
1,259
1,394
Cash paid for income taxes, net
362
510
Cash outflows for lease liabilities
101
99
Non-cash right-of-use (“ROU”) assets recorded for new and modified leases
91
78
Non-cash acquisition-related contingent consideration
$ 177
$ 0
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION (Unaudited) - USD ($)
$ in Millions
Jun. 30, 2026
Sep. 30, 2025
Assets:
Cash and cash equivalents
$ 9,977
$ 11,389
Assets segregated for regulatory purposes and restricted cash
3,277
3,398
Collateralized agreements
1,165
698
Financial instruments, at fair value:
Trading assets ($1,410 and $1,248 pledged as collateral)
1,627
1,538
Available-for-sale securities ($8 and $9 pledged as collateral)
6,496
6,888
Derivative assets
32
68
Other investments ($20 and $8 pledged as collateral)
383
390
Brokerage client receivables, net
3,331
2,821
Other receivables, net
2,465
1,814
Deferred income taxes, net
465
671
Goodwill and identifiable intangible assets, net
2,608
1,847
Other assets
4,115
3,515
Total assets
94,237
88,230
Liabilities and shareholders’ equity:
Bank deposits
63,319
58,897
Collateralized financings
829
1,111
Financial instrument liabilities, at fair value:
Trading liabilities
891
891
Derivative liabilities
215
190
Brokerage client payables
6,882
5,853
Accrued compensation, commissions and benefits
2,555
2,603
Other payables
2,291
1,961
Other borrowings
950
700
Senior notes payable
3,522
3,520
Total liabilities
81,454
75,726
Commitments and contingencies (see Note 17)
Shareholders’ equity
Preferred stock
0
79
Common stock; $.01 par value; 650,000,000 shares authorized; 250,084,168 shares issued and 192,124,666 shares outstanding as of June 30, 2026; 250,084,168 shares issued and 198,139,594 shares outstanding as of September 30, 2025
3
3
Additional paid-in capital
3,204
3,235
Retained earnings
14,977
13,604
Treasury stock, at cost; 57,959,502 and 51,944,574 common shares as of June 30, 2026 and September 30, 2025, respectively
(5,104)
(4,022)
Accumulated other comprehensive loss
(381)
(396)
Total equity attributable to Raymond James Financial, Inc.
12,699
12,503
Noncontrolling interests
84
1
Total shareholders’ equity
12,783
12,504
Total liabilities and shareholders’ equity
94,237
88,230
Nonrelated party
Financial instruments, at fair value:
Loans, net
56,227
51,567
Related party
Financial instruments, at fair value:
Loans, net
$ 2,069
$ 1,626